Anúncio
Anúncio

PHAR

PHAR logo

Pharming Group N.V. ADS, each representing 10 ordinary shares

18.63
USD
Patrocinado
+0.74
+4.14%
09 de jan., 15:33 UTC -5
Encerrado
exchange

Pós-Mercado

18.45

-0.18
-0.97%

Relatórios de Lucros PHAR

Rácio de surpresa positiva

PHAR separação 20 de 39 últimas estimativas.

51%

Próximo Relatório

Data do Próximo Relatório
11 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$104.74M
/
$0.00
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+7.65%
/
-100.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+13.02%
/
--

Pharming Group N.V. ADS, each representing 10 ordinary shares earnings per share and revenue

On 06 de nov. de 2025, PHAR reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of 0.00 USD, resulting in a 1100.00% surprise. Revenue reached 97.30 milhão, compared to an expected 96.23 milhão, with a 1.11% difference. The market reacted with a +11.53% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of 0.00 USD, with revenue projected to reach 104.74 milhão USD, implying an diminuir of -100.00% EPS, and aumentar of 7.65% in Revenue from the last quarter.
FAQ
For Q3 2025, Pharming Group N.V. ADS, each representing 10 ordinary shares reported EPS of $0.01, beating estimates by 1100%, and revenue of $97.30M, 1.11% above expectations.
The stock price moved up 11.53%, changed from $13.18 before the earnings release to $14.70 the day after.
The next earning report is scheduled for 11 de mar. de 2026.
Based on 6 analistas, Pharming Group N.V. ADS, each representing 10 ordinary shares is expected to report EPS of -- and revenue of $104.74M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio